A phase I/II study for intrathecal administration of recombinant human hepatocyte growth factor in patients with acute spinal cord injury: a double-blind, randomized clinical trial of safety and efficacy.
Bibliographic Information
- Title
- A phase I/II study for intrathecal administration of recombinant human hepatocyte growth factor in patients with acute spinal cord injury: a double-blind, randomized clinical trial of safety and efficacy.
- Author
- Nagoshi N, Tsuji O, Kitamura K, Suda K, Maeda T, Yato Y, Abe T, Hayata D, Matsumoto M, Okano H, Nakamura M.
Journal
-
- Journal of Neurotrauma
-
Journal of Neurotrauma - 2020
- Tweet
Details 詳細情報について
-
- CRID
- 1011694355638762240
-
- Article Type
- journal article
-
- Data Source
-
- KAKEN